Presentations

April 12, 2018
Poster presentation of preliminary data from the ongoing extension period of the Phase 2 trial with WTX101 presented at the EASL meeting
View here

March 21, 2018
Capital markets Day 2018
View webcast here
View presentation material here

March 12, 2018
Wilson Therapeutics at Cowen & Company 38th Annual Healthcare Conference
View here

March 6, 2018
Wilson Therapeutics at Stockholm Corporate Finance Life Science Seminar (Swedish)
View here

February 21, 2018
Presentation of the year-end report for 2017
View webcast here
View presentation material here

November 23, 2017
Presentation of the interim report for the third quarter 2017
View webcast here
View presentation material here

November 14, 2017
Wilson Therapeutics at Stora Aktiedagen Stockholm (Swedish)
View here

October 25, 2017
Presentation of preliminary data from the ongoing extension period of the Phase 2 trial with WTX101 by Professor Michael L. Schilsky. Recording of webcast hosted by DNB.
View here

August 28, 2017
Presentation of current treatments for Wilson Disease with a focus on novel treatment perspectives
View here

August 24, 2017
Presentation of the interim report for the second quarter 2017
View webcast here
View presentation material here

May 17, 2017
Presentation of the interim report for the first quarter 2017
View webcast here
View presentation material here

April 24, 2017
Presentation of final Phase 2 data from the Phase 2 trial with WTX101 with Professor Karl Heinz Weiss. Recording of presentation held at the EASL meeting.
View here

Dec 5, 2016
Presentation of Phase 2 topline data
View webcast here
View presentation material here